Fungal keratitis treatment: Unveiling strategies and emerging trends - A systematic review
Abstract
This study evaluates the efficacy of antifungal medications for fungal keratitis through a systematic review in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. A comprehensive search of PubMed, Cochrane, and ScienceDirect was performed, including randomized controlled trials (RCT), cohort, and case-control studies on antifungal therapy for fungal keratitis. Keywords and MeSH terms, including "keratitis," "fungal keratitis," "antifungal," and "therapy," were used to identify relevant studies. The screening process was facilitated through Rayyan, an online-based platform. The inclusion criteria were English-language, full-text human studies on antifungal therapy. Data extraction included study details, interventions, outcomes, and adverse effects, with efficacy evaluated on a scale of 0-2 based on clinical outcomes. Twelve RCT involving 1.715 adult patients from India, China, and Nepal were reviewed. The mean patient age was 48.1 years, with males predominating. All studies used 5% natamycin eye drops, with seven incorporating voriconazole in various forms. Additional therapies included chlorhexidine, amphotericin B, ciprofloxacin, levofloxacin, hypochlorous acid (HOCI), and ketoconazole. Seven studies reported significant improvements in best-corrected visual acuity, infiltrate size, and treatment success. Natamycin monotherapy was shown to have the highest efficacy with a score of 11. Combination therapies, including…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 715 participants or records.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.